EyePoint Pharmaceuticals Inc. buy TD Cowen
Start price
20.12.25
/
50%
€14.75
Target price
20.12.26
-
Performance (%)
-72.47%
Price
14.08.26
€11.40
Summary
This prediction is currently active. The BUY prediction by TD_Cowen for EyePoint Pharmaceuticals Inc. is performing very badly with a performance of -72.47%. This prediction currently runs until 20.12.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | 4.587% | 4.587% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by TD_Cowen for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (NASDAQ:EYPT) was upgraded by analysts at TD Cowen to a "strong-buy" rating.
Ratings data for EYPT provided by MarketBeat

